BioSpace News Archive

Torchmark Corporation (NYSE: TMK) will release Fourth Quarter 2018 earnings after the market closes on Tuesday, February 5, 2019.

Patent broadens protection in infectious disease, including composition of matter claims [23-January-2019] PRINCETON, N.J. , Jan. 23, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical n

New interoperability initiative enables patients and providers to review, store, and share health data across 24 hospitals

Self Care Catalysts, a digital health company specializing in helping patients with self care through digital therapeutics backed by real-world evidence, is pleased to announce that Dr. Ethan Basch has joined as a Scientific Advisor.

STEMCELL Technologies has released mTeSR™ Plus, an enhanced version of mTeSR™1, the most widely published feeder-free human pluripotent stem cell (hPSC) maintenance medium.

MediSapiens, a leading developer and provider of genomic, biomedical and health data solutions, has partnered with Modul-Bio, a leading provider of solutions for biological sample management, Biobank Information Management Systems (BIMS) and collaborative tools for sharing biological sample collections.

Rebound Therapeutics® Corporation announced FDA 510k clearance of their AURORA Surgiscope® System, the world’s first single-use disposable Neurosurgical Endoscope for minimally invasive access, visualization and illumination of the target neuro anatomy

Presentation coincided with launch of a private-label CoPrimer product

Rhinoplasty Reigns Supreme, Millennials Are The New Influencers, Return To Natural Look Is Trending, Non-Invasive Treatments Continue to Surge

Fourth Quarter 2018 Highlights